Literature DB >> 23408426

Tyrosine sulfation of chemokine receptor CCR2 enhances interactions with both monomeric and dimeric forms of the chemokine monocyte chemoattractant protein-1 (MCP-1).

Joshua H Y Tan1, Justin P Ludeman, Jamie Wedderburn, Meritxell Canals, Pam Hall, Stephen J Butler, Deni Taleski, Arthur Christopoulos, Michael J Hickey, Richard J Payne, Martin J Stone.   

Abstract

Chemokine receptors are commonly post-translationally sulfated on tyrosine residues in their N-terminal regions, the initial site of binding to chemokine ligands. We have investigated the effect of tyrosine sulfation of the chemokine receptor CCR2 on its interactions with the chemokine monocyte chemoattractant protein-1 (MCP-1/CCL2). Inhibition of CCR2 sulfation, by growth of expressing cells in the presence of sodium chlorate, significantly reduced the potency for MCP-1 activation of CCR2. MCP-1 exists in equilibrium between monomeric and dimeric forms. The obligate monomeric mutant MCP-1(P8A) was similar to wild type MCP-1 in its ability to induce leukocyte recruitment in vivo, whereas the obligate dimeric mutant MCP-1(T10C) was less effective at inducing leukocyte recruitment in vivo. In two-dimensional NMR experiments, sulfated peptides derived from the N-terminal region of CCR2 bound to both the monomeric and dimeric forms of wild type MCP-1 and shifted the equilibrium to favor the monomeric form. Similarly, MCP-1(P8A) bound more tightly than MCP-1(T10C) to the CCR2-derived sulfopeptides. NMR chemical shift mapping using the MCP-1 mutants showed that the sulfated N-terminal region of CCR2 binds to the same region (N-loop and β3-strand) of both monomeric and dimeric MCP-1 but that binding to the dimeric form also influences the environment of chemokine N-terminal residues, which are involved in dimer formation. We conclude that interaction with the sulfated N terminus of CCR2 destabilizes the dimerization interface of inactive dimeric MCP-1, thus inducing dissociation to the active monomeric state.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23408426      PMCID: PMC3617241          DOI: 10.1074/jbc.M112.447359

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Structure of a CXC chemokine-receptor fragment in complex with interleukin-8.

Authors:  N J Skelton; C Quan; D Reilly; H Lowman
Journal:  Structure       Date:  1999-02-15       Impact factor: 5.006

2.  Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry.

Authors:  M Farzan; T Mirzabekov; P Kolchinsky; R Wyatt; M Cayabyab; N P Gerard; C Gerard; J Sodroski; H Choe
Journal:  Cell       Date:  1999-03-05       Impact factor: 41.582

3.  Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1.

Authors:  M P Crump; J H Gong; P Loetscher; K Rajarathnam; A Amara; F Arenzana-Seisdedos; J L Virelizier; M Baggiolini; B D Sykes; I Clark-Lewis
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

4.  Mapping the binding surface of interleukin-8 complexed with an N-terminal fragment of the type 1 human interleukin-8 receptor.

Authors:  R T Clubb; J G Omichinski; G M Clore; A M Gronenborn
Journal:  FEBS Lett       Date:  1994-01-24       Impact factor: 4.124

Review 5.  Chemokine receptor 2 (CCR2) in atherosclerosis, infectious diseases, and regulation of T-cell polarization.

Authors:  Israel F Charo; Wendy Peters
Journal:  Microcirculation       Date:  2003-06       Impact factor: 2.628

6.  Monomeric monocyte chemoattractant protein-1 (MCP-1) binds and activates the MCP-1 receptor CCR2B.

Authors:  C D Paavola; S Hemmerich; D Grunberger; I Polsky; A Bloom; R Freedman; M Mulkins; S Bhakta; D McCarley; L Wiesent; B Wong; K Jarnagin; T M Handel
Journal:  J Biol Chem       Date:  1998-12-11       Impact factor: 5.157

7.  Analysis of post-translational CCR8 modifications and their influence on receptor activity.

Authors:  Julio Gutiérrez; Leonor Kremer; Angel Zaballos; Iñigo Goya; Carlos Martínez-A; Gabriel Márquez
Journal:  J Biol Chem       Date:  2004-01-21       Impact factor: 5.157

8.  Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues.

Authors:  J H Gong; I Clark-Lewis
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

9.  Complete amino acid sequence of a human monocyte chemoattractant, a putative mediator of cellular immune reactions.

Authors:  E A Robinson; T Yoshimura; E J Leonard; S Tanaka; P R Griffin; J Shabanowitz; D F Hunt; E Appella
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

10.  Heteronuclear (1H, 13C, 15N) NMR assignments and solution structure of the monocyte chemoattractant protein-1 (MCP-1) dimer.

Authors:  T M Handel; P J Domaille
Journal:  Biochemistry       Date:  1996-05-28       Impact factor: 3.162

View more
  38 in total

1.  Sulfopeptide probes of the CXCR4/CXCL12 interface reveal oligomer-specific contacts and chemokine allostery.

Authors:  Joshua J Ziarek; Anthony E Getschman; Stephen J Butler; Deni Taleski; Bryan Stephens; Irina Kufareva; Tracy M Handel; Richard J Payne; Brian F Volkman
Journal:  ACS Chem Biol       Date:  2013-06-26       Impact factor: 5.100

Review 2.  Chemokines and chemokine receptors: update on utility and challenges for the clinician.

Authors:  Ishan Roy; Douglas B Evans; Michael B Dwinell
Journal:  Surgery       Date:  2014-02-08       Impact factor: 3.982

3.  Evaluation and extension of the two-site, two-step model for binding and activation of the chemokine receptor CCR1.

Authors:  Julie Sanchez; Zil E Huma; J Robert Lane; Xuyu Liu; Jessica L Bridgford; Richard J Payne; Meritxell Canals; Martin J Stone
Journal:  J Biol Chem       Date:  2018-12-19       Impact factor: 5.157

Review 4.  NADPH oxidases: an overview from structure to innate immunity-associated pathologies.

Authors:  Arvind Panday; Malaya K Sahoo; Diana Osorio; Sanjay Batra
Journal:  Cell Mol Immunol       Date:  2014-09-29       Impact factor: 11.530

Review 5.  Role of tyrosine-sulfated proteins in retinal structure and function.

Authors:  Y Kanan; M R Al-Ubaidi
Journal:  Exp Eye Res       Date:  2015-04       Impact factor: 3.467

Review 6.  Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity.

Authors:  E Sachiko Seilie; Juliane Bubeck Wardenburg
Journal:  Semin Cell Dev Biol       Date:  2017-04-23       Impact factor: 7.727

7.  Chemokine CXCL1 dimer is a potent agonist for the CXCR2 receptor.

Authors:  Aishwarya Ravindran; Kirti V Sawant; Jose Sarmiento; Javier Navarro; Krishna Rajarathnam
Journal:  J Biol Chem       Date:  2013-03-11       Impact factor: 5.157

Review 8.  Emerging patterns of tyrosine sulfation and O-glycosylation cross-talk and co-localization.

Authors:  Akul Y Mehta; Jamie Heimburg-Molinaro; Richard D Cummings; Christoffer K Goth
Journal:  Curr Opin Struct Biol       Date:  2020-01-09       Impact factor: 6.809

Review 9.  The structural role of receptor tyrosine sulfation in chemokine recognition.

Authors:  Justin P Ludeman; Martin J Stone
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

10.  Polysialylation controls dendritic cell trafficking by regulating chemokine recognition.

Authors:  Eva Kiermaier; Christine Moussion; Christopher T Veldkamp; Rita Gerardy-Schahn; Ingrid de Vries; Larry G Williams; Gary R Chaffee; Andrew J Phillips; Friedrich Freiberger; Richard Imre; Deni Taleski; Richard J Payne; Asolina Braun; Reinhold Förster; Karl Mechtler; Martina Mühlenhoff; Brian F Volkman; Michael Sixt
Journal:  Science       Date:  2015-12-10       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.